INSMInsmed Incorporated
$100.66-30% 1Y
$100.66
$91.8852 weeks$211.41
Is the price fair?
What INSM's price assumes
Insmed Incorporated did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 19.9× revenue.
19.9
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 29.9
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 19.4
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 29.9
- EV / EBIToperating margin −74%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 19.4
- Market capitalisation
- $22.6B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #38 of 196 by RyuScore